Case Report: Safety and Efficacy of Tocilizumab in a Patient with Rheumatoid Arthritis and Chronic Hepatitis C
Tocilizumab is a monoclonal humanized anti-IL-6-receptor antibody used for the treatment of rheumatoid arthritis. The safety of tocilizumab in HCV patients is an open question. We report on safety and efficacy of tocilizumab in a 71-year-old female with rheumatoid arthritis and chronic hepatitis C....
Saved in:
Main Authors: | Filippo Iebba, Fiorella Di Sora, Agapito Tarasi, Wilma Leti, Tatiana Montella, Francesco Montella |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/212381 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tocilizumab Was Effective in Repairing the Large Geode in a Patient with Rheumatoid Arthritis
by: Takuya Izumiyama, et al.
Published: (2020-01-01) -
Tocilizumab modulates the activity of the classical and alternative complement pathways in rheumatoid arthritis patients
by: Iván Ferraz-Amaro, et al.
Published: (2025-01-01) -
Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
by: Jiangtao Li, et al.
Published: (2013-01-01) -
A Case of Rheumatoid Arthritis and Limited Systemic Sclerosis Overlap Successfully Treated with Tocilizumab for Arthritis and Concomitant Generalized Lymphadenopathy and Primary Biliary Cirrhosis
by: Eiko Saito, et al.
Published: (2014-01-01) -
Work loss in patients with rheumatoid arthritis treated with abatacept, rituximab, tocilizumab or TNF inhibitors: a nationwide direct drug-to-drug comparison
by: Ulf Lindström, et al.
Published: (2025-01-01)